Angiotensin-converting enzyme inhibitor versus calcium antagonist in the treatment of hypertension.

Details

Serval ID
serval:BIB_10BFD37CEF57
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Angiotensin-converting enzyme inhibitor versus calcium antagonist in the treatment of hypertension.
Journal
Nephron
Author(s)
Brunner H.R., Bidiville J., Waeber G., Porchet M., Nussberger J., Waeber B.
ISSN
0028-2766
Publication state
Published
Issued date
1987
Peer-reviewed
Oui
Volume
47 Suppl 1
Pages
87-9
Language
english
Notes
Publication types: Clinical Trial ; Comparative Study ; Journal Article ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't - Publication Status: ppublish
Abstract
Sixteen patients with essential hypertension were treated for 2 consecutive 6-week periods with either the angiotensin-converting enzyme (ACE) inhibitor enalapril (20 mg once daily) or the calcium antagonist diltiazem (120 mg twice daily). The sequence of the treatment phases was randomly allocated. Blood pressure decreased from 154/102 +/- 5/2 mm Hg (mean +/- SEM) to 135/96 +/- 4/2 and 140/98 +/- 3/2 mm Hg during treatment with enalapril and diltiazem, respectively. It was impossible in the individual hypertensive patient to predict the long-term blood pressure response to one of the agents studied based on the long-term blood pressure response to the other agent.
Keywords
Adult, Blood Pressure, Diltiazem, Enalapril, Female, Humans, Hypertension, Male, Middle Aged
Pubmed
Web of science
Create date
05/03/2008 16:40
Last modification date
20/08/2019 12:37
Usage data